GT Biopharma, Inc. (GTBP)

0.435 -0.02 (-3.33%) USD  |  NASDAQ  |  Feb 24, 11:37
More

GT Biopharma Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for GTBP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
SELLAS Life Sciences Group, Inc. Upgrade
Lyell Immunopharma, Inc. Upgrade
Geron Corp. --
Regeneron Pharmaceuticals, Inc. Upgrade
Crinetics Pharmaceuticals, Inc. Upgrade